Back to News
Market Impact: 0.1

VIG ETF Factor Report

VIGNDAQ
Company FundamentalsAnalyst InsightsCapital Returns (Dividends / Buybacks)Technology & InnovationHealthcare & Biotech
VIG        ETF Factor Report

Validea's fundamental report characterizes the Vanguard Dividend Appreciation ETF (VIG) as a Large-Cap Quality ETF, demonstrating significant exposure to Quality (95) and Low Volatility (92) factors, while exhibiting lower exposure to Value (40) and Momentum (37). The ETF's portfolio is primarily allocated to the Technology sector and the Biotechnology & Drugs industry, providing a clear profile of its underlying factor biases and sector concentration for institutional analysis.

Analysis

Validea's fundamental report provides a clear factor-based profile of the Vanguard Dividend Appreciation ETF (VIG), identifying it as a Large-Cap Quality vehicle. The analysis reveals an exceptionally high exposure to the Quality factor, with a score of 95, and a similarly strong tilt towards Low Volatility, scoring 92. This characterization suggests the ETF's holdings are concentrated in stable, financially sound companies. Conversely, VIG shows significantly lower exposure to Value and Momentum factors, with scores of 40 and 37 respectively, indicating it is not designed to capture returns from either deep value or high-trending stocks. The portfolio's composition underpins this factor profile, with its largest concentrations in the Technology sector and the Biotechnology & Drugs industry, highlighting where the strategy finds its target dividend-appreciating, high-quality names.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

neutral

Sentiment Score

0.00

Ticker Sentiment

NDAQ0.00
VIG0.00

Key Decisions for Investors

  • Investors seeking a core holding with defensive characteristics should consider VIG due to its very high exposure to Quality (95) and Low Volatility (92) factors.
  • Given the ETF's low exposure to Value (40) and Momentum (37), it may be prudent to pair VIG with other funds to achieve a more balanced factor diversification within a portfolio.
  • The significant concentration in the Technology and Biotechnology & Drugs sectors introduces sector-specific risks and opportunities, requiring investors to monitor trends and regulatory changes impacting these industries.
  • VIG is best utilized as a vehicle for long-term, risk-managed growth and should not be mistaken for a broad market index fund due to its distinct factor tilts and sector concentrations.